C

Celltrion Pharm Inc
KOSDAQ:068760

Watchlist Manager
Celltrion Pharm Inc
KOSDAQ:068760
Watchlist
Price: 58 000 KRW -2.36% Market Closed
Market Cap: 2.5T KRW

Wall Street
Price Targets

Price Targets Summary
Celltrion Pharm Inc

There are no price targets for Celltrion Pharm Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Celltrion Pharm Inc Competitors:
Price Targets
4552
JCR Pharmaceuticals Co Ltd
6% Downside
ARVN
Arvinas Inc
13% Upside
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
34% Upside
300363
Porton Pharma Solutions Ltd
32% Upside
4503
Astellas Pharma Inc
8% Downside
MEGA
Mega Lifesciences PCL
4% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
32% Upside
SUPN
Supernus Pharmaceuticals Inc
25% Upside

Revenue
Forecast

Revenue Estimate
Celltrion Pharm Inc

For the last 13 years the compound annual growth rate for Celltrion Pharm Inc's revenue is 20%. The projected CAGR for the next 7 years is 10%.

20%
Past Growth
10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Celltrion Pharm Inc

For the last 13 years the compound annual growth rate for Celltrion Pharm Inc's operating income is 15%. The projected CAGR for the next 7 years is 45%.

15%
Past Growth
45%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Celltrion Pharm Inc

For the last 13 years the compound annual growth rate for Celltrion Pharm Inc's net income is 15%. The projected CAGR for the next 7 years is 26%.

15%
Past Growth
26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Celltrion Pharm Inc's stock price target?
Not Available

Celltrion Pharm Inc doesn't have any price targets made by Wall Street professionals.

What is Celltrion Pharm Inc's Revenue forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Celltrion Pharm Inc's revenue is 20%. The projected CAGR for the next 7 years is 10%.

What is Celltrion Pharm Inc's Operating Income forecast?
Projected CAGR
45%

For the last 13 years the compound annual growth rate for Celltrion Pharm Inc's operating income is 15%. The projected CAGR for the next 7 years is 45%.

What is Celltrion Pharm Inc's Net Income forecast?
Projected CAGR
26%

For the last 13 years the compound annual growth rate for Celltrion Pharm Inc's net income is 15%. The projected CAGR for the next 7 years is 26%.

Back to Top